Home Amines 445430-59-1
445430-59-1,MFCD07784499
Catalog No.:AA01X587

445430-59-1 | 1,2-Ethanediamine, N1-(1,8-dimethylimidazo[1,2-a]quinoxalin-4-yl)-, hydrochloride (1:?)

This product is typically in stock,please click "Inquire" below or
contact us at [email protected] for pricing and availability information.
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Literature
Technical Information
Catalog Number:
AA01X587
Chemical Name:
1,2-Ethanediamine, N1-(1,8-dimethylimidazo[1,2-a]quinoxalin-4-yl)-, hydrochloride (1:?)
CAS Number:
445430-59-1
Molecular Formula:
C14H18ClN5
Molecular Weight:
291.7792
MDL Number:
MFCD07784499
SMILES:
NCCNc1nc2ccc(cc2n2c1ncc2C)C.Cl
Properties
Computed Properties
 
Complexity:
310  
Covalently-Bonded Unit Count:
2  
Heavy Atom Count:
20  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
3  
Rotatable Bond Count:
3  

Literature

Title: Sirtuin-1 (SIRT1) is required for promoting chondrogenic differentiation of mesenchymal stem cells.

Journal: The Journal of biological chemistry 20140808

Title: Inhibition of type I interferon-mediated antiviral action in human glioma cells by the IKK inhibitors BMS-345541 and TPCA-1.

Journal: Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 20120801

Title: Flavivirus infection induces indoleamine 2,3-dioxygenase in human monocyte-derived macrophages via tumor necrosis factor and NF-κB.

Journal: Journal of leukocyte biology 20120401

Title: Targeting IKK/NF-κB pathway reduces infiltration of inflammatory cells and apoptosis after spinal cord injury in rats.

Journal: Neuroscience letters 20120305

Title: IκB kinases modulate the activity of the androgen receptor in prostate carcinoma cell lines.

Journal: Neoplasia (New York, N.Y.) 20120301

Title: Activation of the IκB kinase complex by HTLV-1 Tax requires cytosolic factors involved in Tax-induced polyubiquitination.

Journal: Journal of biochemistry 20111201

Title: Targeting AML through DR4 with a novel variant of rhTRAIL.

Journal: Journal of cellular and molecular medicine 20111001

Title: AMP-activated protein kinase suppresses matrix metalloproteinase-9 expression in mouse embryonic fibroblasts.

Journal: The Journal of biological chemistry 20110506

Title: Improved intraportal islet transplantation outcome by systemic IKK-beta inhibition: NF-κB activity in pancreatic islets depends on oxygen availability.

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20110201

Title: IKKβ regulates the repair of DNA double-strand breaks induced by ionizing radiation in MCF-7 breast cancer cells.

Journal: PloS one 20110101

Title: IGF-1 and PDGF-bb suppress IL-1β-induced cartilage degradation through down-regulation of NF-κB signaling: involvement of Src/PI-3K/AKT pathway.

Journal: PloS one 20110101

Title: Small molecule inhibitors of IkappaB kinase signaling inhibit osteoclast formation in vitro and prevent ovariectomy-induced bone loss in vivo.

Journal: FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20101101

Title: In CD28-costimulated human naïve CD4+ T cells, I-κB kinase controls the expression of cell cycle regulatory proteins via interleukin-2-independent mechanisms.

Journal: Immunology 20101001

Title: Up-regulation of bradykinin receptors in rat bronchi via I kappa B kinase-mediated inflammatory signaling pathway.

Journal: European journal of pharmacology 20100525

Title: Characterizing the involvement of the nuclear factor-kappa B (NF kappa B) transcription factor in uveal melanoma.

Journal: Investigative ophthalmology & visual science 20100401

Title: Primary human acute myelogenous leukemia cells release matrix metalloproteases and their inhibitors: release profile and pharmacological modulation.

Journal: European journal of haematology 20100301

Title: Targeting the angiopoietin (Ang)/Tie-2 pathway in the crosstalk between acute myeloid leukaemia and endothelial cells: studies of Tie-2 blocking antibodies, exogenous Ang-2 and inhibition of constitutive agonistic Ang-1 release.

Journal: Expert opinion on investigational drugs 20100201

Title: A role for IL-17 in induction of an inflammation at the fetomaternal interface in preterm labour.

Journal: Journal of reproductive immunology 20100101

Title: Targeting the Fanconi anemia/BRCA pathway circumvents drug resistance in multiple myeloma.

Journal: Cancer research 20091215

Title: The effect of microenvironmental CD40 signals on TRAIL- and drug-induced apoptosis in follicular lymphoma cells.

Journal: Scandinavian journal of immunology 20091201

Title: Tumor necrosis factor-alpha (TNF-alpha) induces upregulation of RhoA via NF-kappaB activation in cultured human bronchial smooth muscle cells.

Journal: Journal of pharmacological sciences 20090801

Title: Inflammatory NF-kappaB activation promotes hepatic apolipoprotein B100 secretion: evidence for a link between hepatic inflammation and lipoprotein production.

Journal: American journal of physiology. Gastrointestinal and liver physiology 20090601

Title: p65 activity and ZAP-70 status predict the sensitivity of chronic lymphocytic leukemia cells to the selective IkappaB kinase inhibitor BMS-345541.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20090415

Title: Molecular determinants of melanoma malignancy: selecting targets for improved efficacy of chemotherapy.

Journal: Molecular cancer therapeutics 20090301

Title: Inhibition of IkappaB kinase-beta and anticancer activities of novel chalcone adamantyl arotinoids.

Journal: Journal of medicinal chemistry 20080911

Title: Diverse TNFalpha-induced death pathways are enhanced by inhibition of NF-kappaB.

Journal: International journal of oncology 20071201

Title: Activin A is an anticatabolic autocrine cytokine in articular cartilage whose production is controlled by fibroblast growth factor 2 and NF-kappaB.

Journal: Arthritis and rheumatism 20071101

Title: The IKK inhibitor BMS-345541 affects multiple mitotic cell cycle transitions.

Journal: Cell cycle (Georgetown, Tex.) 20071015

Title: IFN-gamma-induced upregulation of Fcgamma-receptor-I during activation of monocytic cells requires the PKR and NFkappaB pathways.

Journal: Molecular immunology 20070101

Title: Duration and intensity of NF-kappaB activity determine the severity of endotoxin-induced acute lung injury.

Journal: Journal of immunology (Baltimore, Md. : 1950) 20060415

Title: BMS-345541 targets inhibitor of kappaB kinase and induces apoptosis in melanoma: involvement of nuclear factor kappaB and mitochondria pathways.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20060201

Title: IKK mediates ischemia-induced neuronal death.

Journal: Nature medicine 20051201

Title: Collagen and aggrecan degradation is blocked in interleukin-1-treated cartilage explants by an inhibitor of IkappaB kinase through suppression of metalloproteinase expression.

Journal: The Journal of pharmacology and experimental therapeutics 20051001

Title: Inhibition of IKK down-regulates antigen + IgE-induced TNF production by mast cells: a role for the IKK-IkappaB-NF-kappaB pathway in IgE-dependent mast cell activation.

Journal: Journal of leukocyte biology 20050601

Title: Anti-inflammatory inhibitors of IkappaB kinase in asthma and COPD.

Journal: Current opinion in investigational drugs (London, England : 2000) 20041101

Title: A highly selective inhibitor of IkappaB kinase, BMS-345541, augments graft survival mediated by suboptimal immunosuppression in a murine model of cardiac graft rejection.

Journal: Transplantation 20040415

Title: An inhibitor of IkappaB kinase, BMS-345541, blocks endothelial cell adhesion molecule expression and reduces the severity of dextran sulfate sodium-induced colitis in mice.

Journal: Inflammation research : official journal of the European Histamine Research Society ... [et al.] 20031201

Title: A highly selective inhibitor of I kappa B kinase, BMS-345541, blocks both joint inflammation and destruction in collagen-induced arthritis in mice.

Journal: Arthritis and rheumatism 20030901

Title: BMS-345541 is a highly selective inhibitor of I kappa B kinase that binds at an allosteric site of the enzyme and blocks NF-kappa B-dependent transcription in mice.

Journal: The Journal of biological chemistry 20030117

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 445430-59-1
Tags:445430-59-1 Molecular Formula|445430-59-1 MDL|445430-59-1 SMILES|445430-59-1 1,2-Ethanediamine, N1-(1,8-dimethylimidazo[1,2-a]quinoxalin-4-yl)-, hydrochloride (1:?)